DESCRIPTION

Zejula is a cancer drug which is used as a “maintenance”  treatment to keep certain types of cancer from coming back such as epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.  To buy Zeluja or to know its price contact 3S Corporation.

Manufacturer : Tesaro Inc.

ADDITIONAL INFORMATION

Strengths available :  100 mg

Form :  Capsules

Dosage : Usual Adult Dose for Ovarian Cancer: 300 mg orally once a day.

Duration of Therapy: Until disease progression or unacceptable toxicity.

Usual Adult Dose for Fallopian Tube Cancer:300 mg orally once a day.

Duration of Therapy: Until disease progression or unacceptable toxicity.

Usual Adult Dose for Peritoneal Cancer:300 mg orally once a day.

Duration of Therapy: Until disease progression or unacceptable toxicity.

Storage : Store at 20° to 25°C

Is the medicine US FDA  approved : Yes

Date of Approval : March 27, 2017

SIDE EFFECTS

Common side effects may include indigestion, stomach pain, loss of appetite, nausea, vomiting; constipation, diarrhea; irregular heartbeats, feeling short of breath; abnormal liver function tests; dry mouth, mouth sores; altered sense of taste; back pain, muscle or joint pain; feeling tired; headache, dizziness, anxiety; sleep problems (insomnia); sore throat; or rash.

PACK SIZE

Bottle of 90 capsules

3S Corporation is a WHO GDSP approved & licensed Pharmaceutical stockist/wholesaler/distributor/exporter/importer of Zejula Niraparib 100 mg based in India - To buy Zejula Niraparib 100 mg or know its cost price contact us here.

We supply & sell Zejula Niraparib 100 mg for Reference Listed Drugs, Government Tenders, Shortage Lists, Emergency Imports, Name Patient Drugs, Comparator Drug Studies, Un-licensed Importation, clinical trial samples & Bio-Similars.

Disclaimer: All trademarks, logos and brand names are the property of their respective owners, used here solely for identification & reference only under Section 30(1) of the Trade Marks Act, 1999. We are not affiliated with or endorsed by them unless explicitly stated. By using this website, you agree to these terms.